Integrated Research Limited

ASX:IRI Lagerbericht

Marktkapitalisierung: AU$55.1m

Integrated Research Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Integrated Research wird ein jährliches Gewinn- und Umsatzwachstum von 18.4% bzw. 7.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 15.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.1% betragen.

Wichtige Informationen

18.4%

Wachstumsrate der Gewinne

15.38%

EPS-Wachstumsrate

Software Gewinnwachstum23.8%
Wachstumsrate der Einnahmen7.7%
Zukünftige Eigenkapitalrendite5.06%
Analystenabdeckung

Low

Zuletzt aktualisiert28 Feb 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Analyse-Update Apr 20

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research steady at A$0.36. Only small technical adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions informed the updated price target stance.
Analyse-Update Apr 05

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept the A$ price target for Integrated Research broadly unchanged, with only a marginal adjustment that reflects slightly updated assumptions for discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Integrated Research has scheduled an Analyst/Investor Day focused on outlining its product vision for the business.
Analyse-Update Mar 22

IRI: Steady Assumptions And Product Vision Update Will Support Long Term Upside

Analysts have kept the price target for Integrated Research steady at A$0.36, citing only minor tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major shift in the outlook. What's in the News Integrated Research has scheduled an Analyst and Investor Day, giving you a chance to hear directly from management about the business and its direction (company event filing).
Analyse-Update Mar 08

IRI: Revised Margins And P/E Assumptions Will Support Long Term Upside

Analysts have trimmed their fair value estimate for Integrated Research from A$0.40 to A$0.36. This reflects updated assumptions that pair a slightly higher discount rate and future P/E multiple with more cautious profit margin expectations and revised revenue growth forecasts.
Analyse-Update Feb 21

IRI: New AI Observability Capabilities Will Support Long Term Upside Potential

Analysts have slightly trimmed their price target for Integrated Research to A$0.40, reflecting small updates to discount rate assumptions and expected future P/E, while keeping fair value and key operating assumptions broadly unchanged. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform.
Analyse-Update Feb 06

IRI: New AI Observability Platform Will Support Long Term Upside

Analysts have adjusted their price target for Integrated Research to account for a slightly higher discount rate and a modestly revised future P/E expectation, resulting in a small change in estimated valuation levels. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform and designed to turn complex monitoring data into plain language answers for IT teams and business users.
Analyseartikel Feb 06

Is Now The Time To Look At Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
Analyse-Update Jan 23

IRI: New AI Observability Layer Will Support Long Term Upside

Analysts have made only a marginal adjustment to their price target for Integrated Research, reflecting slightly updated views on discount rates, long term revenue growth, profit margins, and the future P/E multiple, while keeping their fair value estimate broadly in line with prior assumptions. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis platform, designed to turn complex observability data from unified communications and collaboration environments into plain language insights for IT and business users.
Analyse-Update Jan 08

IRI: Cloud Observability Services And AI Features Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research broadly steady, making only minor tweaks to inputs such as discount rate, revenue growth, profit margin and future P/E. These changes feed into a small adjustment in the overall price target and reflect a largely unchanged view of the company’s medium term risk and earnings profile.
Analyse-Update Dec 17

IRI: Cloud Observability Expansion Is Expected To Support Long Term Upside

Analysts have modestly raised their integrated research price target, citing incremental adjustments to discount rate assumptions and forward valuation multiples that support a fair value estimate now framed around improved long term earnings visibility. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis observability platform.
Analyse-Update Dec 02

IRI: New Cloud Platform Launch Is Expected To Drive Future Upside

Analysts have slightly reduced their price target for Integrated Research, reflecting minor adjustments in discount rate and future price-to-earnings assumptions. Key financial projections remain essentially unchanged.
Analyse-Update Nov 18

IRI: Revenue Setbacks Will Be Outweighed By New Platform Launch

Analysts have revised their price target for Integrated Research downward from $0.55 to $0.40. They cite lowered revenue growth projections and compressed profit margins as the primary factors behind the adjustment.
Analyseartikel Nov 14

Integrated Research Limited's (ASX:IRI) Prospects Need A Boost To Lift Shares

Integrated Research Limited's ( ASX:IRI ) price-to-earnings (or "P/E") ratio of 4.1x might make it look like a strong...
Analyseartikel Aug 30

Integrated Research (ASX:IRI) Is Paying Out A Dividend Of A$0.02

The board of Integrated Research Limited ( ASX:IRI ) has announced that it will pay a dividend on the 21st of October...
Analyse-Update Aug 27

Revenue May Stabilize While Profit Margins Decline In The Coming Years

Despite a notable increase in consensus revenue growth forecasts, a sharp decline in the future P/E multiple has driven the consensus analyst price target for Integrated Research down from A$0.70 to A$0.55. What's in the News Integrated Research previewed enhanced Cisco cloud migration solutions at Cisco Live, offering deeper visibility, real-time and intelligent insights.
Analyseartikel Aug 11

Some Investors May Be Worried About Integrated Research's (ASX:IRI) Returns On Capital

ASX:IRI 1 Year Share Price vs Fair Value Explore Integrated Research's Fair Values from the Community and select yours...
Analyseartikel Jun 16

When Should You Buy Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a double-digit share price...
Analyseartikel May 09

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

Integrated Research Limited ( ASX:IRI ) shareholders would be excited to see that the share price has had a great...
User avatar
Neue Analyse Feb 09

Shifting To High-Value Clients And Launching IR Labs May Improve Stability, But Challenges Remain

Strategic focus on high-value enterprise customers and efficient cost management is expected to enhance net margins and revenue stability.
Analyseartikel Oct 22

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 17...
Analyseartikel Aug 29

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Last week's profit announcement from Integrated Research Limited ( ASX:IRI ) was underwhelming for investors, despite...
Analyseartikel Aug 21

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Integrated Research Limited ( ASX:IRI ) shares have had a horrible month, losing 37% after a relatively good period...
Analyseartikel Jun 28

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Integrated Research Limited ( ASX:IRI ) shares have been powering on, with a gain of 33...
Analyseartikel Jun 11

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Analyseartikel Apr 20

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Integrated Research Limited's ( ASX:IRI ) price-to-sales (or "P/S") ratio of 0.8x might make it look like a buy right...
Analyseartikel Mar 02

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analyseartikel Dec 27

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
Analyseartikel Nov 21

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Key Insights Using the Dividend Discount Model, Integrated Research fair value estimate is AU$0.30 Integrated...
Analyseartikel Aug 28

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

While Integrated Research Limited ( ASX:IRI ) might not be the most widely known stock at the moment, it received a lot...
Analyseartikel May 12

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it received a lot of attention from...
Analyseartikel Jan 11

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it received a lot of attention from a...
Analyseartikel Nov 24

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Today we will run through one way of estimating the intrinsic value of Integrated Research Limited ( ASX:IRI ) by...
Analyseartikel Jul 22

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it led the ASX gainers with a...
Analyseartikel May 16

Is Integrated Research (ASX:IRI) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Apr 05

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Gewinn- und Umsatzwachstumsprognosen

ASX:IRI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
6/30/2028787N/A51
6/30/2027714N/A-21
6/30/202660-1N/A51
12/31/20256871314N/A
9/30/202568101111N/A
6/30/2025681389N/A
3/31/2025701799N/A
12/31/202471211010N/A
9/30/202477241112N/A
6/30/202483271313N/A
3/31/20247831315N/A
12/31/202372-211316N/A
9/30/202371-251015N/A
6/30/202370-29614N/A
3/31/202369-13212N/A
12/31/2022693-19N/A
9/30/2022662213N/A
6/30/2022632517N/A
3/31/2022706618N/A
12/31/20217710718N/A
9/30/2021789820N/A
6/30/2021788921N/A
3/31/20218510922N/A
12/31/20209212922N/A
9/30/202010118923N/A
6/30/202011124924N/A
3/31/2020107231025N/A
12/31/2019104221125N/A
9/30/201910222N/A23N/A
6/30/201910122N/A21N/A
3/31/20199822N/A22N/A
12/31/20189622N/A23N/A
9/30/20189320N/A22N/A
6/30/20189119N/A21N/A
3/31/20189220N/A22N/A
12/31/20179420N/A23N/A
9/30/20179219N/A25N/A
6/30/20179119N/A26N/A
3/31/20179018N/A24N/A
12/31/20168818N/A22N/A
9/30/20168717N/A19N/A
6/30/20168516N/A16N/A
3/31/20168014N/A16N/A
12/31/20157613N/A17N/A
9/30/20157314N/A19N/A
6/30/20157014N/A21N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: IRIDas prognostizierte Gewinnwachstum (18.4% pro Jahr) liegt über der Sparquote (3.6%).

Ertrag vs. Markt: IRIDie Erträge des Unternehmens (18.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (12% pro Jahr).

Hohe Wachstumserträge: IRIDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: IRIDie Einnahmen des Unternehmens (7.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (6.4% pro Jahr).

Hohe Wachstumseinnahmen: IRIDie Einnahmen des Unternehmens (7.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: IRIDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.1%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/09 18:28
Aktienkurs zum Tagesende2026/05/08 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/06/30

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Integrated Research Limited wird von 4 Analysten beobachtet. 1 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Chris SavageBell Potter
Katie BelleLodge Partners Pty Ltd.
Todd GuyotMA Moelis Australia Securities Pty Ltd